SWTX Insider Trading Activity and SEC Form 4 Filings
SWTX insider trading summary
No open-market insider purchases or sales of SpringWorks Therapeutics, Inc. (SWTX) have been reported on SEC Form 4 in the past 12 months.
Latest SWTX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Mar 3, 2025 | Badreddin Edris | Chief Operating Officer | Sell | $208K (3,924 @ $53.12) |
| Mar 3, 2025 | Badreddin Edris | Chief Operating Officer | Sell | $22K (400 @ $56.20) |
| Mar 3, 2025 | Badreddin Edris | Chief Operating Officer | Sell | $655K (12,078 @ $54.26) |
| Mar 3, 2025 | Badreddin Edris | Chief Operating Officer | Sell | $198K (3,598 @ $55.12) |
| Mar 3, 2025 | Saqib Islam | Chief Executive Officer | Sell | $1.3M (23,600 @ $54.24) |
| Mar 3, 2025 | Saqib Islam | Chief Executive Officer | Sell | $625K (11,800 @ $52.97) |
| Mar 3, 2025 | Saqib Islam | Chief Executive Officer | Sell | $79K (1,400 @ $56.13) |
| Mar 3, 2025 | Saqib Islam | Chief Executive Officer | Sell | $34K (600 @ $56.89) |
| Mar 3, 2025 | Saqib Islam | Chief Executive Officer | Sell | $640K (11,600 @ $55.15) |
| Feb 20, 2025 | Bhavesh Ashar | Chief Commercial Officer | Sell | $62K (1,016 @ $61.19) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.